This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Randoph B DePrince
Introduction
Randoph B DePrince is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptides and compounds that interact with specific receptors. His work has implications for treating various hematological disorders.
Latest Patents
Randoph B DePrince holds a patent for "Peptides and compounds that bind to a receptor." This patent describes peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. These innovations are particularly useful in treating thrombocytopenia, which can result from chemotherapy, radiation therapy, or bone marrow transfusions. Additionally, his work includes diagnostic methods that utilize labeled peptides and peptide mimetics.
Career Highlights
DePrince is associated with Glaxo Group Limited, where he has been able to apply his expertise in a collaborative environment. His career has been marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Randoph B DePrince has worked alongside esteemed colleagues such as William J Dower and Ronald W Barrett. These collaborations have further enriched his contributions to the field.
Conclusion
Randoph B DePrince exemplifies the spirit of innovation in biotechnology, with his work paving the way for new treatments and diagnostic methods in hematological disorders. His contributions are a testament to the impact of dedicated inventors in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile